Pavel Klein

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    aquestive
    Topic: 
    drug development/marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    Eisai
    Topic: 
    drug development/marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    neurelis
    Topic: 
    Drug development/marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    UCB Pharma
    Topic: 
    Drug development /marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    SKL science
    Topic: 
    Drug development/marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    Sunovion
    Topic: 
    speaker
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    Arvelle
    Topic: 
    drug developkment/marketing
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    lundbeck
    Topic: 
    drug development
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    Xenon
    Topic: 
    drug development
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent Contractor (including contracted research)
    Ineligible company: 
    Cerevele
    Topic: 
    Drug development
    Date added: 
    01/06/2022
    Relationship end date: 
    01/06/2022

Pages

Return to 2022 Epilepsy Board Review and Best Practices Course